Previous studies (28–31) have shown that tumor size, multifocality, histologic tumor type, lymphovascular space invasion, ER status, PR status, and HER-2 status can be independent predictors of breast cancer with SLNM. This evidence concerns the gene ERBB2 and breast cancer.